KCa3.1 shows high expression also in pancreatic ductal adenocarcinoma (PDAC) [18], melanoma [19], triple-negative breast cancer (TNBC) [20] and non-small cell lung cancer [21]. This evidence concerns the gene KCNN4 and melanoma.